319
Views
18
CrossRef citations to date
0
Altmetric
studies in humans

Is coffee consumption associated with a lower level of serum C-reactive protein? A meta-analysis of observational studies

ORCID Icon & ORCID Icon
Pages 985-994 | Received 08 Nov 2017, Accepted 21 Jan 2018, Published online: 06 Feb 2018

References

  • Arsenault BJ, Earnest CP, Despres JP, Blair SN, Church TS. 2009. Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use. Eur J Clin Nutr. 63:1419–1424.
  • Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50:1088–1101.
  • Bjerkeset O, Romild U, Smith GD, Hveem K. 2011. The associations of high levels of C-reactive protein with depression and myocardial infarction in 9258 women and men from the HUNT population study. Psychol Med. 41:345–352.
  • Calabro P, Chang DW, Willerson JT, Yeh ET. 2005. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 46:1112–1113.
  • Chan DS, Bandera EV, Greenwood DC, Norat T. 2015. Circulating C-reactive protein and breast cancer risk-systematic literature review and meta-analysis of prospective cohort studies. Cancer Epidemiol Biomarkers Prev. 24:1439–1449.
  • Chou WC, Kao MC, Yue CT, Tsai PS, Huang CJ. 2015. Caffeine mitigates lung inflammation induced by ischemia-reperfusion of lower limbs in rats. Mediators Inflamm. 2015:Article ID 361638. doi: 10.1155/2015/361638
  • Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature. 420:860–867.
  • Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore J, Pepys MB. 2000. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 321:199–204.
  • Fang S, Wang Y, Sui D, Liu H, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Schacherer CW, et al. 2015. C-reactive protein as a marker of melanoma progression. J Clin Oncol. 33:1389–1396.
  • Gan Y, Wu J, Zhang S, Li L, Cao S, Mkandawire N, Ji K, Herath C, Gao C, Xu H, et al. 2017. Association of coffee consumption with risk of colorectal cancer: a meta-analysis of prospective cohort studies. Oncotarget. 8:18699–18711.
  • Godos J, Biondi A, Galvano F, Basile F, Sciacca S, Giovannucci EL, Grosso G. 2017. Markers of systemic inflammation and colorectal adenoma risk: meta-analysis of observational studies. World J Gastroenterol. 23:1909–1919.
  • Godos J, Micek A, Marranzano M, Salomone F, Rio DD, Ray S. 2017. Coffee consumption and risk of biliary tract cancers and liver cancer: a dose-response meta-analysis of prospective cohort studies. Nutrients. 9:950. doi: 10.3390/nu9090950
  • Grosso G, Godos J, Galvano F, Giovannucci EL. 2017. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 37:131–156.
  • Grosso G, Micek A, Castellano S, Pajak A, Galvano F. 2016. Coffee, tea, caffeine and risk of depression: a systematic review and dose-response meta-analysis of observational studies. Mol Nutr Food Res. 60:223–234.
  • Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Bes-Rastrollo M, Galvano F, Martinez-Gonzalez MA. 2017. Long-term coffee consumption is associated with decreased incidence of new-onset hypertension: a dose-response meta-analysis. Nutrients. 9:E890. doi: 10.3390/nu9080890
  • Grosso G, Micek A, Godos J, Sciacca S, Pajak A, Martinez-Gonzalez MA, Giovannucci EL, Galvano F. 2016. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol. 31:1191–1205.
  • Higdon JV, Frei B. 2006. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr. 46:101–123.
  • Howren MB, Lamkin DM, Suls J. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 71:171–186.
  • Iso H, Date C, Wakai K, Fukui M, Tamakoshi A. 2006. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med. 144:554–562.
  • Jacobs S, Kroger J, Floegel A, Boeing H, Drogan D, Pischon T, Fritsche A, Prehn C, Adamski J, Isermann B, et al. 2014. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. Am J Clin Nutr. 100:891–900.
  • Jiang W, Wu Y, Jiang X. 2013. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol. 129:620–629.
  • Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Keys MH. 1986. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 124:903–915.
  • Kim JY, Kim DH, Jeong HG. 2006. Inhibitory effect of the coffee diterpene kahweol on carrageenan-induced inflammation in rats. Biofactors. 26:17–28.
  • Kotani K, Sakane N, Yamada T, Taniguchi N. 2010. Association between coffee consumption and the estimated glomerular filtration rate in the general Japanese population: preliminary data regarding C-reactive protein concentrations. Clin Chem Lab Med. 48:1773–1776.
  • Kotani K, Tsuzaki K, Sano Y, Maekawa M, Fujiwara S, Hamada T, Sakane N. 2008. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med. 46:1434–1437.
  • Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, Wan Q, He R, Wang Z. 2017. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Atherosclerosis. 259:75–82.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 339:b2700.
  • Lopez-Garcia E, van Dam RM, Qi L, Hu FB. 2006. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 84:888–893.
  • Maki T, Pham NM, Yoshida D, Yin G, Ohnaka K, Takayanagi R, Kono S. 2010. The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women. Clin Chem Lab Med. 48:849–854.
  • Marventano S, Salomone F, Godos J, Pluchinotta F, Del Rio D, Mistretta A, Grosso G. 2016. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clin Nutr. 35:1269–1281.
  • Micek A, Godos J, Lafranconi A, Marranzano M, Pajak A. 2017. Caffeinated and decaffeinated coffee consumption and melanoma risk: a dose-response meta-analysis of prospective cohort studies. Int J Food Sci Nutr. [accessed 2017 Sep 11]:[10 p.]. doi: 10.1080/09637486.2017.1373752
  • Nanri A, Moore MA, Kono S. 2007. Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev. 8:167–177.
  • Owoyele BV, Oyewole AL, Biliaminu SA, Alashi Y. 2015. Effect of taurine and caffeine on plasma C-reactive protein and calcium in Wistar rats. Afr J Med Med Sci. 44:229–236.
  • Paiva CLRS, Beserra BTS, Reis CEG, Dorea JG, Da Costa THM, Amato AA. 2017. Consumption of coffee or caffeine and serum concentration of inflammatory markers: a systematic review. Crit Rev Food Sci Nutr. [accessed 2017 Nov 3]:[12 p.]. doi: 10.1080/10408398.2017.1386159
  • Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RR, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation. 107:499–511.
  • Pham NM, Wang Z, Morita M, Ohnaka K, Adachi M, Kawate H, Takayanagi R, Kono S. 2011. Combined effects of coffee consumption and serum γ-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women. Clin Chem Lab Med. 49:1661–1667.
  • Poddubnyy DA, Rudwaleit M, Listing J, Braun J, Sieper J. 2010. Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Ann Rheum Dis. 69:1338–1341.
  • Qi H, Li S. 2014. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr Gerontol Int. 14:430–439.
  • Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y. 2016. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 73:1316–1324.
  • Rebello SA, Chen CH, Naidoo N, Xu W, Lee J, Chia KS, Tai ES, van Dam RM. 2011. Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: a cross-sectional study. Nutr J. 10:61. doi: 10.1186/1475-2891-10-61
  • Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, Hu FB. 2004. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 140:1–8. doi: 10.7326/0003-4819-140-1-200401060-00005
  • Weichelt U, Cay R, Schmitz T, Strauss E, Sifringer M, Buhrer C, Endesfelder S. 2013. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J. 41:966–973.
  • Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest. 115:1111–1119.
  • Wells GA, Shea B, Connell DO, Peterson J, Welch V, Losos M, Tugwell P. 2010. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 50:1088–1101. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kajii E. 2001. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol. 153:1183–1190.
  • Yamashita K, Yatsuya H, Muramatsu T, Toyoshima H, Murohara T, Tamakoshi K. 2012. Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes. 2:e33. doi: 10.1038/nutd.2012.6
  • Yeh YC, Lei HJ, Chen MH, Ho HL, Chiu LY, Li CP, Wang YC. 2017. C-Reactive Protein (CRP) is a promising diagnostic immunohistochemical marker for intrahepatic cholangiocarcinoma and is associated with better prognosis. Am J Surg Pathol. 41:1630–1641.
  • Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. 2004. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr. 80:862–867.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.